|
Study Region
| | | | | | |
---|
|
Karen
|
Kachin
|
Chin
| | | | | |
---|
Number of study sites
|
4
|
5
|
4
| | | | | | |
---|
Population
|
6176
|
4170
|
4636
|
(Total population: 14,982)
|
| | | | |
Percentage of study participants % (number)
|
Study participantsb
|
Karen
|
Kachin
|
Chin
|
Total study participants
| |
RDT result availablea
|
Pf positive by RDT
|
Tested by PCR
|
Pf positive by PCR
|
Age <5 years
|
459
|
284
|
201
|
17% (944)
|
99% (938)
|
13% (121)
|
34% (327)
|
5% (49)
|
5-15 years
|
717
|
662
|
522
|
33% (1,901)
|
99% (1,881)
|
15% (281)
|
36% (684)
|
7% (138)
|
>15 years
|
996
|
947
|
873
|
50% (2,816)
|
97% (2,752)
|
13% (371)
|
34% (964)
|
4% (99)
|
Female
|
1,152
|
1118
|
801
|
54% (3,071)
|
99% (3,038)
|
12% (375)
|
35% (1,070)
|
4% (136)
|
Asymptomatic screening participants
|
1,900
|
1,639
|
1,178
|
80% (4,717)
|
97% (4,591)
|
9% (430)
|
32% (1,507)
|
3% (157)
|
Febrile clinical patients
|
536
|
254
|
427
|
20% (1,217)
|
81% (988)
|
35% (343)
|
42% (506)
|
11% (133)
|
Total participants
|
2,436
|
1,893
|
1,605
|
5,934
|
94% (5,579)
|
14% (773)
|
34% (2013)
|
5% (290)
|
- RDT rapid diagnostic test; PCR polymerase chain reaction; Pf Plasmodium falciparum.
- a The second round of clinic treatment books in Karen sites were not available to link RDT results to filter-paper blood spots (n = 228). All filter samples were eligible for selection for PCR.
- b Cells do not add to 5,934 due to missing age and sex data; percentages may not add to 100% due to rounding.